<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <meta http-equiv="Content-Security-Policy" content="script-src 'none'">
    <title>NIAID News (@NIAIDNews)</title>
    <style>
      body {
        font-family: Arial, Helvetica, sans-serif;
        max-width: 800px;
      }
      .profile {
        font-height: 24px;
        font-weight: bold;
        margin-left: 4px;
      }
      .profile img {
        height: 24px;
        width: 24px;
      }
      .profile .user { color: #888 }
      .tweet .head {
        font-weight: bold;
        margin: 8px;
      }
      .tweet .head .id { display: none }
      .tweet .head .user { color: #888 }
      .tweet .head .time { margin-left: 4px }
      .tweet .head a {
        color: black;
        text-decoration: none;
      }
      .tweet .content { margin: 4px }
      .tweet .content img, .tweet .content svg {
        max-height: 300px;
        max-width: 300px;
      }
      .tweet .text { display: none }
      .tweet hr { border: solid 1px #ddd }
      .sep { border: solid 1px black }
    </style>
  </head>
  <body>
    <div class="profile">
      <img src="https://pbs.twimg.com/profile_images/915948170303111169/VQKi3e_U_normal.jpg">
      NIAID News
      <span class="user">@NIAIDNews</span>
    </div>
    <hr class="sep">
    <div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344694563181481985">
          <span class="id">1344694563181481985</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-31 13:19:01</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>NEWS: NIAID scientists further validate </span><span><a dir="ltr" href="https://twitter.com/hashtag/RTQuIC?src=hashtag_click" role="link" data-focusable="true">#RTQuIC</a></span><span> test to diagnose </span><span><a dir="ltr" href="https://twitter.com/hashtag/Parkinson?src=hashtag_click" role="link" data-focusable="true">#Parkinson</a></span><span>‚Äôs disease. Spinal fluid sample yields result in 1-2 days with high accuracy.</span></div></div><hr/><br/><div><div><div><div><div data-testid="card.wrapper"><div aria-hidden="true" data-testid="card.layoutSmall.media" style="width: calc(124.438px);"><a href="https://t.co/JkHnJm6ojc?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><div><div style="padding-bottom: 100%;"></div><div><div aria-label="" style="margin-bottom: 0px; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/card_img/1342795338390806531/KBVehzQz?format=jpg&amp;name=240x240&#34;);"></div><img alt="" draggable="true" src="https://pbs.twimg.com/card_img/1342795338390806531/KBVehzQz?format=jpg&amp;name=240x240"/></div></div></div></a></div><div><a href="https://t.co/JkHnJm6ojc?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><div data-testid="card.layoutSmall.detail"><div><div dir="auto"><span><span><b>A rapid Œ±‚Äêsynuclein seed assay of Parkinson‚Äôs disease CSF panel shows high diagnostic accuracy</b></span></span></div></div><div><div dir="auto" style="-webkit-line-clamp: 2;"><span><span>Background Assays that specifically measure Œ±‚Äêsynuclein seeding activity in biological fluids could revolutionize the diagnosis of Parkinson‚Äôs disease. Recent improvements in Œ±‚Äêsynuclein real‚Äêtime...</span></span></div></div><div><div dir="auto"><span><svg viewBox="0 0 24 24"><g><path d="M11.96 14.945c-.067 0-.136-.01-.203-.027-1.13-.318-2.097-.986-2.795-1.932-.832-1.125-1.176-2.508-.968-3.893s.942-2.605 2.068-3.438l3.53-2.608c2.322-1.716 5.61-1.224 7.33 1.1.83 1.127 1.175 2.51.967 3.895s-.943 2.605-2.07 3.438l-1.48 1.094c-.333.246-.804.175-1.05-.158-.246-.334-.176-.804.158-1.05l1.48-1.095c.803-.592 1.327-1.463 1.476-2.45.148-.988-.098-1.975-.69-2.778-1.225-1.656-3.572-2.01-5.23-.784l-3.53 2.608c-.802.593-1.326 1.464-1.475 2.45-.15.99.097 1.975.69 2.778.498.675 1.187 1.15 1.992 1.377.4.114.633.528.52.928-.092.33-.394.547-.722.547z"></path><path d="M7.27 22.054c-1.61 0-3.197-.735-4.225-2.125-.832-1.127-1.176-2.51-.968-3.894s.943-2.605 2.07-3.438l1.478-1.094c.334-.245.805-.175 1.05.158s.177.804-.157 1.05l-1.48 1.095c-.803.593-1.326 1.464-1.475 2.45-.148.99.097 1.975.69 2.778 1.225 1.657 3.57 2.01 5.23.785l3.528-2.608c1.658-1.225 2.01-3.57.785-5.23-.498-.674-1.187-1.15-1.992-1.376-.4-.113-.633-.527-.52-.927.112-.4.528-.63.926-.522 1.13.318 2.096.986 2.794 1.932 1.717 2.324 1.224 5.612-1.1 7.33l-3.53 2.608c-.933.693-2.023 1.026-3.105 1.026z"></path></g></svg></span><span><span><i>onlinelibrary.wiley.com</i></span></span></div></div></div></a></div></div></div></div></div></div></div></div>
      <div class="text">NEWS: NIAID scientists further validate #RTQuIC test to diagnose #Parkinson ‚Äôs disease. Spinal fluid sample yields result in 1-2 days with high accuracy. A rapid Œ±‚Äêsynuclein seed assay of Parkinson‚Äôs disease CSF panel shows high diagnostic accuracy Background Assays that specifically measure Œ±‚Äêsynuclein seeding activity in biological fluids could revolutionize the diagnosis of Parkinson‚Äôs disease. Recent improvements in Œ±‚Äêsynuclein real‚Äêtime... onlinelibrary.wiley.com</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344691367339933697">
          <span class="id">1344691367339933697</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-31 13:06:19</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>NEJM paper details mRNA-1273 vaccine&#39;s 94.1% efficacy in preventing symptomatic COVID-19 when tested in Phase 3 clinical trial. Vaccine co-developed by Moderna and NIH also effective at preventing severe COVID-19. Study findings at: DOI: 10.1056/NEJMoa2035389 (2020).</span></div></div></div></div>
      <div class="text">NEJM paper details mRNA-1273 vaccine&#39;s 94.1% efficacy in preventing symptomatic COVID-19 when tested in Phase 3 clinical trial. Vaccine co-developed by Moderna and NIH also effective at preventing severe COVID-19. Study findings at: DOI: 10.1056/NEJMoa2035389 (2020).</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344282091098259457">
          <span class="id">1344282091098259457</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-30 10:00:00</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span><a dir="ltr" href="https://twitter.com/hashtag/ScienceHighlights2020?src=hashtag_click" role="link" data-focusable="true">#ScienceHighlights2020</a></span><span> </span><span>üî¨</span><span>: This year, researchers made enormous strides in understanding, preventing &amp; treating </span><span><a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click" role="link" data-focusable="true">#COVID19</a></span><span>. Other work brought scientific advances in </span><span><a dir="ltr" href="https://twitter.com/hashtag/HIV?src=hashtag_click" role="link" data-focusable="true">#HIV</a></span><span>, </span><span><a dir="ltr" href="https://twitter.com/hashtag/tuberculosis?src=hashtag_click" role="link" data-focusable="true">#tuberculosis</a></span><span>, </span><span><a dir="ltr" href="https://twitter.com/hashtag/eczema?src=hashtag_click" role="link" data-focusable="true">#eczema</a></span><span> &amp; many additional areas: </span><a dir="ltr" href="https://t.co/0XB3M9qiAZ?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">http://</span>bit.ly/2020NIAIDHighl<span aria-hidden="true">ights</span><span aria-hidden="true">‚Ä¶</span></a></div></div><hr/><br/><div><div><div><div><div><div style="padding-bottom: 79%;"></div><div><div data-testid="placementTracking"><div data-testid="videoPlayer"><div><div style="padding-bottom: 79%;"></div><div><div style="height: 100%; position: relative; transform: translateZ(0px); width: 100%;"><div style="height: 100%; position: absolute; width: 100%;"><div style="position: relative; width: 100%; height: 100%; background-color: transparent; overflow: hidden;"><video preload="auto" playsinline="" aria-label="Embedded video" poster="https://pbs.twimg.com/tweet_video_thumb/Eqa1k2pXEAYttK-.jpg" src="https://video.twimg.com/tweet_video/Eqa1k2pXEAYttK-.mp4" type="video/mp4" style="width: 100%; height: 100%; position: absolute; background-color: black; top: 0%; left: 0%; transform: rotate(0deg) scale(1.005);" controls=""></video></div></div><div><div><div></div><div aria-label="Play Video" role="button" data-focusable="true" tabindex="0"><div><div style="background-image: url(&#34;https://pbs.twimg.com/tweet_video_thumb/Eqa1k2pXEAYttK-.jpg&#34;);"></div></div></div><div><div role="progressbar" aria-valuemax="1" aria-valuemin="0"><div style="height: 60px; width: 60px;"><svg height="100%" viewBox="0 0 32 32" width="100%"><circle cx="16" cy="16" fill="none" r="14" stroke-width="4" style="stroke: rgb(255, 255, 255); opacity: 0.2;"></circle><circle cx="16" cy="16" fill="none" r="14" stroke-width="4" style="stroke: rgb(255, 255, 255); stroke-dasharray: 80; stroke-dashoffset: 60;"></circle></svg></div></div></div><div style="transition-duration: 250ms; transition-property: opacity, height; transition-timing-function: ease; will-change: opacity; opacity: 1;"><div><div><div dir="auto"><span><span>GIF</span></span></div></div></div></div><div style="transition-duration: 250ms; transition-property: opacity, height; transition-timing-function: ease; will-change: opacity; opacity: 1;"></div><div style="transition-duration: 250ms; transition-property: opacity, height; transition-timing-function: ease; will-change: opacity; opacity: 0;"></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
      <div class="text">#ScienceHighlights2020 üî¨ : This year, researchers made enormous strides in understanding, preventing &amp; treating #COVID19 . Other work brought scientific advances in #HIV , #tuberculosis , #eczema &amp; many additional areas: http:// bit.ly/2020NIAIDHighl ights ‚Ä¶ GIF</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344024492306120704">
          <span class="id">1344024492306120704</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-29 16:56:24</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span><a dir="ltr" href="https://twitter.com/hashtag/Ebanga?src=hashtag_click" role="link" data-focusable="true">#Ebanga</a></span><span> is the 1st product discovered and developed by NIAID‚Äôs Vaccine Research Center to receive </span><span><span><a dir="ltr" href="https://twitter.com/FDA" role="link" data-focusable="true">@FDA</a></span></span><span> license approval and builds upon tools and experience from HIV research. VRC integrates research, process development, manufacturing, clinical testing and sample evaluation.</span></div></div></div></div>
      <div class="text">#Ebanga is the 1st product discovered and developed by NIAID‚Äôs Vaccine Research Center to receive @FDA license approval and builds upon tools and experience from HIV research. VRC integrates research, process development, manufacturing, clinical testing and sample evaluation.</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344024491190435841">
          <span class="id">1344024491190435841</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-29 16:56:24</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span><a dir="ltr" href="https://twitter.com/hashtag/Ebanga?src=hashtag_click" role="link" data-focusable="true">#Ebanga</a></span><span> was licensed to Ridgeback Biotherapeutics in Dec. 2018. Ridgeback and </span><span><span><a dir="ltr" href="https://twitter.com/BARDA" role="link" data-focusable="true">@BARDA</a></span></span><span> partnered in September 2019 for late-stage manufacturing and regulatory activities to support licensure. </span><a dir="ltr" href="https://t.co/MC6QX6YsXd?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">https://</span>medicalcountermeasures.gov/newsroom/2020/<span aria-hidden="true">ridgeback/</span><span aria-hidden="true">‚Ä¶</span></a></div></div></div></div>
      <div class="text">#Ebanga was licensed to Ridgeback Biotherapeutics in Dec. 2018. Ridgeback and @BARDA partnered in September 2019 for late-stage manufacturing and regulatory activities to support licensure. https:// medicalcountermeasures.gov/newsroom/2020/ ridgeback/ ‚Ä¶</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344024489768615937">
          <span class="id">1344024489768615937</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-29 16:56:23</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>The </span><span><a dir="ltr" href="https://twitter.com/hashtag/PALM?src=hashtag_click" role="link" data-focusable="true">#PALM</a></span><span> trial ended early (in Aug 2019) due to data showing patients receiving </span><span><a dir="ltr" href="https://twitter.com/hashtag/Ebanga?src=hashtag_click" role="link" data-focusable="true">#Ebanga</a></span><span> or REGN-EB3 (Inmazeb) had a greater chance of surviving Ebola virus disease. The findings were confirmed in a Nov. 2019 publication </span><a dir="ltr" href="https://t.co/8ZmMQHsyr7?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">https://</span>niaid.nih.gov/news-events/in<span aria-hidden="true">vestigational-drugs-reduce-risk-death-ebola-virus-disease</span><span aria-hidden="true">‚Ä¶</span></a></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIAIDNews/status/1344024489768615937/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="PALM trial logo: the words pamoja tulinde maisha; together save lives; ensemble sauvons les vies surround a drawing of people holding hands in a circle around a tree" data-testid="tweetPhoto" style="margin-bottom: -21%; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EqbrtoKUcAAAKLr?format=png&amp;name=small&#34;);"></div><img alt="PALM trial logo: the words pamoja tulinde maisha; together save lives; ensemble sauvons les vies surround a drawing of people holding hands in a circle around a tree" draggable="true" src="https://pbs.twimg.com/media/EqbrtoKUcAAAKLr?format=png&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">The #PALM trial ended early (in Aug 2019) due to data showing patients receiving #Ebanga or REGN-EB3 (Inmazeb) had a greater chance of surviving Ebola virus disease. The findings were confirmed in a Nov. 2019 publication https:// niaid.nih.gov/news-events/in vestigational-drugs-reduce-risk-death-ebola-virus-disease ‚Ä¶</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344024487742717952">
          <span class="id">1344024487742717952</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-29 16:56:23</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>In Aug. 2018, the </span><span><a dir="ltr" href="https://twitter.com/hashtag/DRC?src=hashtag_click" role="link" data-focusable="true">#DRC</a></span><span> declared the country‚Äôs 10th outbreak of </span><span><a dir="ltr" href="https://twitter.com/hashtag/EVD?src=hashtag_click" role="link" data-focusable="true">#EVD</a></span><span>. In Nov. 2018, </span><span><span><a dir="ltr" href="https://twitter.com/inrb_kinshasa" role="link" data-focusable="true">@inrb_kinshasa</a></span></span><span> and </span><span><a dir="ltr" href="https://twitter.com/hashtag/NIAID?src=hashtag_click" role="link" data-focusable="true">#NIAID</a></span><span> (with </span><span><span><a dir="ltr" href="https://twitter.com/WHO" role="link" data-focusable="true">@WHO</a></span></span><span> support) began a randomized, controlled trial of multiple investigational Ebola therapies, including </span><span><a dir="ltr" href="https://twitter.com/hashtag/Ebanga?src=hashtag_click" role="link" data-focusable="true">#Ebanga</a></span><span>, in the </span><span><a dir="ltr" href="https://twitter.com/hashtag/DRC?src=hashtag_click" role="link" data-focusable="true">#DRC</a></span><span>. </span><a dir="ltr" href="https://t.co/ZEaMzAz7dB?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">https://</span>niaid.nih.gov/news-events/cl<span aria-hidden="true">inical-trial-investigational-ebola-treatments-begins-democratic-republic-congo</span><span aria-hidden="true">‚Ä¶</span></a></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIAIDNews/status/1344024487742717952/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="portable treatment cubes at an Ebola treatment center in Beni" data-testid="tweetPhoto" style="margin-bottom: -1%; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EqbpJBCVQAA5jp4?format=jpg&amp;name=small&#34;);"></div><img alt="portable treatment cubes at an Ebola treatment center in Beni" draggable="true" src="https://pbs.twimg.com/media/EqbpJBCVQAA5jp4?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">In Aug. 2018, the #DRC declared the country‚Äôs 10th outbreak of #EVD . In Nov. 2018, @inrb_kinshasa and #NIAID (with @WHO support) began a randomized, controlled trial of multiple investigational Ebola therapies, including #Ebanga , in the #DRC . https:// niaid.nih.gov/news-events/cl inical-trial-investigational-ebola-treatments-begins-democratic-republic-congo ‚Ä¶</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344024484337000448">
          <span class="id">1344024484337000448</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-29 16:56:22</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>In May 2018, NIAID (with </span><span><span><a dir="ltr" href="https://twitter.com/DARPA" role="link" data-focusable="true">@DARPA</a></span></span><span> support) began enrolling healthy volunteers in a Phase 1 clinical trial of </span><span><a dir="ltr" href="https://twitter.com/hashtag/Ebanga?src=hashtag_click" role="link" data-focusable="true">#Ebanga</a></span><span> at the </span><span><span><a dir="ltr" href="https://twitter.com/NIHClinicalCntr" role="link" data-focusable="true">@NIHClinicalCntr</a></span></span><span>. Results published in Jan. 2019 showed the therapy is safe, well-tolerated, and easy to administer. </span><a dir="ltr" href="https://t.co/cSVobDBPIQ?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">https://</span>niaid.nih.gov/news-events/in<span aria-hidden="true">vestigational-monoclonal-antibody-treat-ebola-safe-adults</span><span aria-hidden="true">‚Ä¶</span></a></div></div></div></div>
      <div class="text">In May 2018, NIAID (with @DARPA support) began enrolling healthy volunteers in a Phase 1 clinical trial of #Ebanga at the @NIHClinicalCntr . Results published in Jan. 2019 showed the therapy is safe, well-tolerated, and easy to administer. https:// niaid.nih.gov/news-events/in vestigational-monoclonal-antibody-treat-ebola-safe-adults ‚Ä¶</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344024483124768768">
          <span class="id">1344024483124768768</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-29 16:56:22</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>Together with </span><span><span><a dir="ltr" href="https://twitter.com/MTamfum" role="link" data-focusable="true">@MTamfum</a></span></span><span>, </span><span><span><a dir="ltr" href="https://twitter.com/inrb_kinshasa" role="link" data-focusable="true">@inrb_kinshasa</a></span></span><span> &amp; the Institute for Research in Biomedicine (Switzerland), Dr. Nancy Sullivan &amp; her team at NIAID‚Äôs VRC isolated </span><span><a dir="ltr" href="https://twitter.com/hashtag/Ebanga?src=hashtag_click" role="link" data-focusable="true">#Ebanga</a></span><span> from a survivor of the 1995 Kikwit Ebola outbreak. Preclinical studies showed promise: </span><a dir="ltr" href="https://t.co/Aq0mYgvGZl?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">https://</span>niaid.nih.gov/news-events/ex<span aria-hidden="true">perimental-ebola-antibody-protects-monkeys</span><span aria-hidden="true">‚Ä¶</span></a></div></div></div></div>
      <div class="text">Together with @MTamfum , @inrb_kinshasa &amp; the Institute for Research in Biomedicine (Switzerland), Dr. Nancy Sullivan &amp; her team at NIAID‚Äôs VRC isolated #Ebanga from a survivor of the 1995 Kikwit Ebola outbreak. Preclinical studies showed promise: https:// niaid.nih.gov/news-events/ex perimental-ebola-antibody-protects-monkeys ‚Ä¶</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344024482059448321">
          <span class="id">1344024482059448321</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-29 16:56:21</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>A longstanding research partnership between </span><span><a dir="ltr" href="https://twitter.com/hashtag/NIAID?src=hashtag_click" role="link" data-focusable="true">#NIAID</a></span><span> scientists and their collaborators in the Democratic Republic of the Congo (</span><span><a dir="ltr" href="https://twitter.com/hashtag/DRC?src=hashtag_click" role="link" data-focusable="true">#DRC</a></span><span>) made this significant achievement possible.</span></div></div></div></div>
      <div class="text">A longstanding research partnership between #NIAID scientists and their collaborators in the Democratic Republic of the Congo ( #DRC ) made this significant achievement possible.</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1344024480926978048">
          <span class="id">1344024480926978048</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-29 16:56:21</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span><a dir="ltr" href="https://twitter.com/hashtag/EBOLA?src=hashtag_click" role="link" data-focusable="true">#EBOLA</a></span><span> NEWS: Last week, </span><span><span><a dir="ltr" href="https://twitter.com/FDA" role="link" data-focusable="true">@FDA</a></span></span><span> approved a single human monoclonal antibody now known as </span><span><a dir="ltr" href="https://twitter.com/hashtag/Ebanga?src=hashtag_click" role="link" data-focusable="true">#Ebanga</a></span><span> (Ansuvimab-zykl, </span><span><a dir="ltr" href="https://twitter.com/hashtag/mAb114?src=hashtag_click" role="link" data-focusable="true">#mAb114</a></span><span>), for the treatment for Zaire ebolavirus (Ebolavirus) infection in adults and children.</span></div></div><hr/><br/><div><div><div><div><div data-testid="card.wrapper"><div aria-hidden="true" data-testid="card.layoutLarge.media"><a href="https://t.co/VZiH1Rrq0y?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><div><div style="padding-bottom: 52.356%;"></div><div><div aria-label="" style="margin-bottom: 0px; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/card_img/1341523775787954176/CQ_3fVrz?format=png&amp;name=small&#34;);"></div><img alt="" draggable="true" src="https://pbs.twimg.com/card_img/1341523775787954176/CQ_3fVrz?format=png&amp;name=small"/></div></div></div></a></div><div><a href="https://t.co/VZiH1Rrq0y?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><div data-testid="card.layoutLarge.detail"><div><div dir="auto"><span><span><b>FDA Approves Treatment for Ebola Virus</b></span></span></div></div><div><div dir="auto" style="-webkit-line-clamp: 2;"><span><span>The FDA approved Ebanga (Ansuvimab-zykl), a human monoclonal antibody, for the treatment for Zaire ebolavirus (Ebolavirus) infection in adults and children.</span></span></div></div><div><div dir="auto"><span><svg viewBox="0 0 24 24"><g><path d="M11.96 14.945c-.067 0-.136-.01-.203-.027-1.13-.318-2.097-.986-2.795-1.932-.832-1.125-1.176-2.508-.968-3.893s.942-2.605 2.068-3.438l3.53-2.608c2.322-1.716 5.61-1.224 7.33 1.1.83 1.127 1.175 2.51.967 3.895s-.943 2.605-2.07 3.438l-1.48 1.094c-.333.246-.804.175-1.05-.158-.246-.334-.176-.804.158-1.05l1.48-1.095c.803-.592 1.327-1.463 1.476-2.45.148-.988-.098-1.975-.69-2.778-1.225-1.656-3.572-2.01-5.23-.784l-3.53 2.608c-.802.593-1.326 1.464-1.475 2.45-.15.99.097 1.975.69 2.778.498.675 1.187 1.15 1.992 1.377.4.114.633.528.52.928-.092.33-.394.547-.722.547z"></path><path d="M7.27 22.054c-1.61 0-3.197-.735-4.225-2.125-.832-1.127-1.176-2.51-.968-3.894s.943-2.605 2.07-3.438l1.478-1.094c.334-.245.805-.175 1.05.158s.177.804-.157 1.05l-1.48 1.095c-.803.593-1.326 1.464-1.475 2.45-.148.99.097 1.975.69 2.778 1.225 1.657 3.57 2.01 5.23.785l3.528-2.608c1.658-1.225 2.01-3.57.785-5.23-.498-.674-1.187-1.15-1.992-1.376-.4-.113-.633-.527-.52-.927.112-.4.528-.63.926-.522 1.13.318 2.096.986 2.794 1.932 1.717 2.324 1.224 5.612-1.1 7.33l-3.53 2.608c-.933.693-2.023 1.026-3.105 1.026z"></path></g></svg></span><span><span><i>fda.gov</i></span></span></div></div></div></a></div></div></div></div></div></div></div></div>
      <div class="text">#EBOLA NEWS: Last week, @FDA approved a single human monoclonal antibody now known as #Ebanga (Ansuvimab-zykl, #mAb114 ), for the treatment for Zaire ebolavirus (Ebolavirus) infection in adults and children. FDA Approves Treatment for Ebola Virus The FDA approved Ebanga (Ansuvimab-zykl), a human monoclonal antibody, for the treatment for Zaire ebolavirus (Ebolavirus) infection in adults and children. fda.gov</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIH/status/1343574559874666497">
          <span class="id">1343574559874666497</span>
          NIH
          <span class="user">@NIH</span>
          <span class="time">2020-12-28 11:08:32</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><b><a href="https://twitter.com/NIH/status/1343574559874666497">NIH (@NIH)</a></b><br/><div><div lang="en" dir="auto"><span>News: Phase 3 trial of Novavax investigational COVID-19 vaccine opens</span></div></div><hr/><br/><div><div><div><div><div data-testid="card.wrapper"><div aria-hidden="true" data-testid="card.layoutLarge.media"><a href="https://t.co/ApJW4gcfeF?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><div><div style="padding-bottom: 52.356%;"></div><div><div aria-label="" style="margin-bottom: 0px; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/card_img/1343633016548110336/dTH0wX1k?format=jpg&amp;name=small&#34;);"></div><img alt="" draggable="true" src="https://pbs.twimg.com/card_img/1343633016548110336/dTH0wX1k?format=jpg&amp;name=small"/></div></div></div></a></div><div><a href="https://t.co/ApJW4gcfeF?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><div data-testid="card.layoutLarge.detail"><div><div dir="auto"><span><span><b>Phase 3 trial of Novavax investigational COVID-19 vaccine opens</b></span></span></div></div><div><div dir="auto" style="-webkit-line-clamp: 2;"><span><span>NIH- and BARDA-funded trial will enroll up to 30,000 volunteers.</span></span></div></div><div><div dir="auto"><span><svg viewBox="0 0 24 24"><g><path d="M11.96 14.945c-.067 0-.136-.01-.203-.027-1.13-.318-2.097-.986-2.795-1.932-.832-1.125-1.176-2.508-.968-3.893s.942-2.605 2.068-3.438l3.53-2.608c2.322-1.716 5.61-1.224 7.33 1.1.83 1.127 1.175 2.51.967 3.895s-.943 2.605-2.07 3.438l-1.48 1.094c-.333.246-.804.175-1.05-.158-.246-.334-.176-.804.158-1.05l1.48-1.095c.803-.592 1.327-1.463 1.476-2.45.148-.988-.098-1.975-.69-2.778-1.225-1.656-3.572-2.01-5.23-.784l-3.53 2.608c-.802.593-1.326 1.464-1.475 2.45-.15.99.097 1.975.69 2.778.498.675 1.187 1.15 1.992 1.377.4.114.633.528.52.928-.092.33-.394.547-.722.547z"></path><path d="M7.27 22.054c-1.61 0-3.197-.735-4.225-2.125-.832-1.127-1.176-2.51-.968-3.894s.943-2.605 2.07-3.438l1.478-1.094c.334-.245.805-.175 1.05.158s.177.804-.157 1.05l-1.48 1.095c-.803.593-1.326 1.464-1.475 2.45-.148.99.097 1.975.69 2.778 1.225 1.657 3.57 2.01 5.23.785l3.528-2.608c1.658-1.225 2.01-3.57.785-5.23-.498-.674-1.187-1.15-1.992-1.376-.4-.113-.633-.527-.52-.927.112-.4.528-.63.926-.522 1.13.318 2.096.986 2.794 1.932 1.717 2.324 1.224 5.612-1.1 7.33l-3.53 2.608c-.933.693-2.023 1.026-3.105 1.026z"></path></g></svg></span><span><span><i>nih.gov</i></span></span></div></div></div></a></div></div></div></div></div></div></div></div>
      <div class="text">NIH (@NIH) News: Phase 3 trial of Novavax investigational COVID-19 vaccine opens Phase 3 trial of Novavax investigational COVID-19 vaccine opens NIH- and BARDA-funded trial will enroll up to 30,000 volunteers. nih.gov</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1341744766287970305">
          <span class="id">1341744766287970305</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-23 09:57:35</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>COVID-19 NEWS: now published in </span><span><span><a dir="ltr" href="https://twitter.com/NEJM" role="link" data-focusable="true">@NEJM</a></span></span><span>: results of a clinical trial testing LY-CoV555 in hospitalized </span><span><a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click" role="link" data-focusable="true">#COVID19</a></span><span> patients showed that it did not provide clinical benefit compared to placebo in that patient population. </span><a dir="ltr" href="https://t.co/y3z6NLTdaU?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">http://</span>bit.ly/38wv2Je</a></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIAIDNews/status/1341744766287970305/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="Image" data-testid="tweetPhoto" style="margin-bottom: -29%; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/Ep7Vp5OUwAA8kxr?format=jpg&amp;name=small&#34;);"></div><img alt="Image" draggable="true" src="https://pbs.twimg.com/media/Ep7Vp5OUwAA8kxr?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">COVID-19 NEWS: now published in @NEJM : results of a clinical trial testing LY-CoV555 in hospitalized #COVID19 patients showed that it did not provide clinical benefit compared to placebo in that patient population. http:// bit.ly/38wv2Je</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIH/status/1341222910065692675">
          <span class="id">1341222910065692675</span>
          NIH
          <span class="user">@NIH</span>
          <span class="time">2020-12-21 23:23:55</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><b><a href="https://twitter.com/NIH/status/1341222910065692675">NIH (@NIH)</a></b><br/><div><div lang="en" dir="auto"><span>Historic event LIVE tomorrow (12/22) @ 10 am ET on </span><span><a dir="ltr" href="https://twitter.com/hashtag/NIH?src=hashtag_click" role="link" data-focusable="true">#NIH</a></span><span>‚Äôs Twitter. Front-line workers from </span><span><span><a dir="ltr" href="https://twitter.com/NIHClinicalCntr" role="link" data-focusable="true">@NIHClinicalCntr</a></span></span><span>, </span><span><span><a dir="ltr" href="https://twitter.com/NIHDirector" role="link" data-focusable="true">@NIHDirector</a></span></span><span>, </span><span><span><a dir="ltr" href="https://twitter.com/NIAIDNews" role="link" data-focusable="true">@NIAIDNews</a></span></span><span> Director Dr. Anthony Fauci, &amp; </span><span><span><a dir="ltr" href="https://twitter.com/SecAzar" role="link" data-focusable="true">@SecAzar</a></span></span><span> will </span><span><a dir="ltr" href="https://twitter.com/hashtag/SleeveUp?src=hashtag_click" role="link" data-focusable="true">#SleeveUp</a></span><span> to receive </span><span><span><a dir="ltr" href="https://twitter.com/moderna_tx" role="link" data-focusable="true">@moderna_tx</a></span></span><span>‚Äôs </span><span><a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click" role="link" data-focusable="true">#COVID19</a></span><span> vaccine, co-developed by NIH. </span><a dir="ltr" href="https://t.co/FehuOhbDJR?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">http://</span>bit.ly/3hbXLXM</a></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIH/status/1341222910065692675/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="Image" data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/Epz6XOeUwAEFNnM?format=png&amp;name=small&#34;);"></div><img alt="Image" draggable="true" src="https://pbs.twimg.com/media/Epz6XOeUwAEFNnM?format=png&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">NIH (@NIH) Historic event LIVE tomorrow (12/22) @ 10 am ET on #NIH ‚Äôs Twitter. Front-line workers from @NIHClinicalCntr , @NIHDirector , @NIAIDNews Director Dr. Anthony Fauci, &amp; @SecAzar will #SleeveUp to receive @moderna_tx ‚Äôs #COVID19 vaccine, co-developed by NIH. http:// bit.ly/3hbXLXM</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1341135816584798208">
          <span class="id">1341135816584798208</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-21 17:37:50</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>.</span><span><span><a dir="ltr" href="https://twitter.com/NIAIDNews" role="link" data-focusable="true">@NIAIDNews</a></span></span><span> scientists demonstrate deep phenotyping of human tissues using IBEX and commercially available antibodies by visualizing </span><span><a dir="ltr" href="https://twitter.com/hashtag/immune?src=hashtag_click" role="link" data-focusable="true">#immune</a></span><span> interactions in a mesenteric </span><span><a dir="ltr" href="https://twitter.com/hashtag/LymphNode?src=hashtag_click" role="link" data-focusable="true">#LymphNode</a></span><span> with </span><span><a dir="ltr" href="https://twitter.com/hashtag/GerminalCenters?src=hashtag_click" role="link" data-focusable="true">#GerminalCenters</a></span><span>:</span></div></div><hr/><br/><div><div><div><div><div><div style="padding-bottom: 56.25%;"></div><div><div data-testid="placementTracking"><div data-testid="videoPlayer"><div><div style="padding-bottom: 56.25%;"></div><div><div style="height: 100%; position: relative; transform: translateZ(0px); width: 100%;"><div style="height: 100%; position: absolute; width: 100%;"><div style="position: relative; width: 100%; height: 100%; background-color: transparent; overflow: hidden;"><video preload="none" playsinline="" aria-label="Embedded video" poster="https://pbs.twimg.com/ext_tw_video_thumb/1341135734565167104/pu/img/Db4r4SK1YSElWRUm.jpg" src="blob:https://twitter.com/a4cbdd3b-3ea2-4374-9f5b-78d75372cd44" style="width: 100%; height: 100%; position: absolute; background-color: black; top: 0%; left: 0%; transform: rotate(0deg) scale(1.005);"></video></div></div><div><div><div></div><div><div><div style="background-image: url(&#34;https://pbs.twimg.com/ext_tw_video_thumb/1341135734565167104/pu/img/Db4r4SK1YSElWRUm.jpg&#34;);"></div></div><div aria-label="Play Video.   21 seconds long. 519 views" role="button" data-focusable="true" tabindex="0"><div><svg viewBox="0 0 24 24"><g><path d="M20.436 11.37L5.904 2.116c-.23-.147-.523-.158-.762-.024-.24.132-.39.384-.39.657v18.5c0 .273.15.525.39.657.112.063.236.093.36.093.14 0 .28-.04.402-.117l14.53-9.248c.218-.138.35-.376.35-.633 0-.256-.132-.495-.348-.633z"></path></g></svg></div></div></div><div><div style="transition-duration: 250ms; transition-property: opacity, height; transition-timing-function: ease; will-change: opacity; opacity: 0;"></div></div><div style="transition-duration: 250ms; transition-property: opacity, height; transition-timing-function: ease; will-change: opacity; opacity: 0;"></div><div style="transition-duration: 250ms; transition-property: opacity, height; transition-timing-function: ease; will-change: opacity; opacity: 1;"></div><div style="transition-duration: 250ms; transition-property: opacity, height; transition-timing-function: ease; will-change: opacity; opacity: 0;"></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
      <div class="text">. @NIAIDNews scientists demonstrate deep phenotyping of human tissues using IBEX and commercially available antibodies by visualizing #immune interactions in a mesenteric #LymphNode with #GerminalCenters :</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1341135313553534976">
          <span class="id">1341135313553534976</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-21 17:35:50</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>IBEX can be applied to capture ultra-high content data from human tissues, as </span><span><span><a dir="ltr" href="https://twitter.com/NIAIDNews" role="link" data-focusable="true">@NIAIDNews</a></span></span><span> scientists demonstrate by visualizing </span><span><a dir="ltr" href="https://twitter.com/hashtag/tumor?src=hashtag_click" role="link" data-focusable="true">#tumor</a></span><span>-</span><span><a dir="ltr" href="https://twitter.com/hashtag/immune?src=hashtag_click" role="link" data-focusable="true">#immune</a></span><span> interactions in a pancreatic </span><span><a dir="ltr" href="https://twitter.com/hashtag/LymphNode?src=hashtag_click" role="link" data-focusable="true">#LymphNode</a></span><span> with </span><span><a dir="ltr" href="https://twitter.com/hashtag/metastatic?src=hashtag_click" role="link" data-focusable="true">#metastatic</a></span><span> lesions:</span></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIAIDNews/status/1341135313553534976/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 50%;"></div><div><div aria-label="Images from IBEX experiments in a human tissue sample from a pancreatic lymph node with metastatic lesions." data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EpyrYTlW4AEGxDY?format=jpg&amp;name=small&#34;);"></div><img alt="Images from IBEX experiments in a human tissue sample from a pancreatic lymph node with metastatic lesions." draggable="true" src="https://pbs.twimg.com/media/EpyrYTlW4AEGxDY?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">IBEX can be applied to capture ultra-high content data from human tissues, as @NIAIDNews scientists demonstrate by visualizing #tumor - #immune interactions in a pancreatic #LymphNode with #metastatic lesions:</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1341134969712861189">
          <span class="id">1341134969712861189</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-21 17:34:28</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>NEWS: </span><span><span><a dir="ltr" href="https://twitter.com/NIAIDNews" role="link" data-focusable="true">@NIAIDNews</a></span></span><span> researchers have developed a new </span><span><a dir="ltr" href="https://twitter.com/hashtag/OpenSource?src=hashtag_click" role="link" data-focusable="true">#OpenSource</a></span><span> method for highly </span><span><a dir="ltr" href="https://twitter.com/hashtag/multiplex?src=hashtag_click" role="link" data-focusable="true">#multiplex</a></span><span> tissue imaging, called IBEX, that can be integrated into most current lab workflows. Read more in </span><span><span><a dir="ltr" href="https://twitter.com/PNASNews" role="link" data-focusable="true">@PNASNews</a></span></span><span>: </span><a dir="ltr" href="https://t.co/YBuqq7eSzL?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">http://</span>bit.ly/IBEX-PNAS</a></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIAIDNews/status/1341134969712861189/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 49.9559%;"></div><div><div aria-label="Confocal images from IBEX experiments with various mouse organs." data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EpyrCLIWwAMwWnZ?format=jpg&amp;name=small&#34;);"></div><img alt="Confocal images from IBEX experiments with various mouse organs." draggable="true" src="https://pbs.twimg.com/media/EpyrCLIWwAMwWnZ?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">NEWS: @NIAIDNews researchers have developed a new #OpenSource method for highly #multiplex tissue imaging, called IBEX, that can be integrated into most current lab workflows. Read more in @PNASNews : http:// bit.ly/IBEX-PNAS</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/SecAzar/status/1341117012064559104">
          <span class="id">1341117012064559104</span>
          Secretary Alex Azar
          <span class="user">@SecAzar</span>
          <span class="time">2020-12-21 16:23:07</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><b><a href="https://twitter.com/SecAzar/status/1341117012064559104">Secretary Alex Azar (@SecAzar)</a></b><br/><div><div lang="en" dir="auto"><span>Tomorrow I&#39;ll receive my COVID-19 vaccine </span><span><span><a dir="ltr" href="https://twitter.com/NIH" role="link" data-focusable="true">@NIH</a></span></span><span> alongside </span><span><span><a dir="ltr" href="https://twitter.com/NIHDirector" role="link" data-focusable="true">@NIHDirector</a></span></span><span>, </span><span><span><a dir="ltr" href="https://twitter.com/NIAIDNews" role="link" data-focusable="true">@NIAIDNews</a></span></span><span> Dr. Fauci, &amp; several </span><span><span><a dir="ltr" href="https://twitter.com/NIHClinicalCntr" role="link" data-focusable="true">@NIHClinicalCntr</a></span></span><span> frontline workers. <br/>
<br/>
We believe it&#39;s important to publicly receive the vaccine as part of our efforts to demonstrate that these vaccines are safe and effective.</span></div></div></div></div>
      <div class="text">Secretary Alex Azar (@SecAzar) Tomorrow I&#39;ll receive my COVID-19 vaccine @NIH alongside @NIHDirector , @NIAIDNews Dr. Fauci, &amp; several @NIHClinicalCntr frontline workers. We believe it&#39;s important to publicly receive the vaccine as part of our efforts to demonstrate that these vaccines are safe and effective.</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIHDirector/status/1341116991525056519">
          <span class="id">1341116991525056519</span>
          Francis S. Collins
          <span class="user">@NIHDirector</span>
          <span class="time">2020-12-21 16:23:02</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><b><a href="https://twitter.com/NIHDirector/status/1341116991525056519">Francis S. Collins (@NIHDirector)</a></b><br/><div><div lang="en" dir="auto"><span>I will receive </span><span><span><a dir="ltr" href="https://twitter.com/moderna_tx" role="link" data-focusable="true">@moderna_tx</a></span></span><span> </span><span><a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click" role="link" data-focusable="true">#COVID19</a></span><span> vaccine alongside </span><span><span><a dir="ltr" href="https://twitter.com/SecAzar" role="link" data-focusable="true">@SecAzar</a></span></span><span>, </span><span><span><a dir="ltr" href="https://twitter.com/NIAIDNews" role="link" data-focusable="true">@NIAIDNews</a></span></span><span> Dr. Fauci, and several </span><span><span><a dir="ltr" href="https://twitter.com/NIHClinicalCntr" role="link" data-focusable="true">@NIHClinicalCntr</a></span></span><span> frontline workers as part of an NIH vaccine kick-off event tomorrow </span><span><span><a dir="ltr" href="https://twitter.com/10amet" role="link" data-focusable="true">@10amET</a></span></span><span>. We at </span><span><a dir="ltr" href="https://twitter.com/hashtag/NIH?src=hashtag_click" role="link" data-focusable="true">#NIH</a></span><span> are proud to have taken part in an amazing journey that will save many lives.</span></div></div></div></div>
      <div class="text">Francis S. Collins (@NIHDirector) I will receive @moderna_tx #COVID19 vaccine alongside @SecAzar , @NIAIDNews Dr. Fauci, and several @NIHClinicalCntr frontline workers as part of an NIH vaccine kick-off event tomorrow @10amET . We at #NIH are proud to have taken part in an amazing journey that will save many lives.</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1341116712519757824">
          <span class="id">1341116712519757824</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-21 16:21:55</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>NIAID Director, Dr. Anthony Fauci will be rolling up his sleeve tomorrow to get </span><span><span><a dir="ltr" href="https://twitter.com/moderna_tx" role="link" data-focusable="true">@moderna_tx</a></span></span><span> </span><span><a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click" role="link" data-focusable="true">#COVID19</a></span><span> vaccine alongside </span><span><span><a dir="ltr" href="https://twitter.com/SecAzar" role="link" data-focusable="true">@SecAzar</a></span></span><span>, </span><span><span><a dir="ltr" href="https://twitter.com/NIHDirector" role="link" data-focusable="true">@NIHDirector</a></span></span><span>, and several </span><span><span><a dir="ltr" href="https://twitter.com/NIHClinicalCntr" role="link" data-focusable="true">@NIHClinicalCntr</a></span></span><span> frontline workers to build confidence in the vaccine, which is the best hope against this pandemic.</span></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIAIDNews/status/1341116712519757824/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="Image" data-testid="tweetPhoto" style="margin-bottom: -27%; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EpyZbjhUUAIkTXx?format=jpg&amp;name=small&#34;);"></div><img alt="Image" draggable="true" src="https://pbs.twimg.com/media/EpyZbjhUUAIkTXx?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">NIAID Director, Dr. Anthony Fauci will be rolling up his sleeve tomorrow to get @moderna_tx #COVID19 vaccine alongside @SecAzar , @NIHDirector , and several @NIHClinicalCntr frontline workers to build confidence in the vaccine, which is the best hope against this pandemic.</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1341114742060929025">
          <span class="id">1341114742060929025</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-21 16:14:05</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>NEWS: NIAID scientists suggest </span><span><a dir="ltr" href="https://twitter.com/hashtag/Reston?src=hashtag_click" role="link" data-focusable="true">#Reston</a></span><span> </span><span><a dir="ltr" href="https://twitter.com/hashtag/ebolavirus?src=hashtag_click" role="link" data-focusable="true">#ebolavirus</a></span><span> be considered a livestock pathogen with potential to affect other mammals, including people, based on a new study of pigs. </span><a dir="ltr" href="https://t.co/zu07sOgyzD?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">https://</span>bit.ly/3h7SEHM</a></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIAIDNews/status/1341114742060929025/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="This colorized transmission electron micrograph shows a slice of Reston virus particles (blue) in the lung of an infected pig." data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: -15%;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EpyYni1VgAAGbjS?format=png&amp;name=small&#34;);"></div><img alt="This colorized transmission electron micrograph shows a slice of Reston virus particles (blue) in the lung of an infected pig." draggable="true" src="https://pbs.twimg.com/media/EpyYni1VgAAGbjS?format=png&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">NEWS: NIAID scientists suggest #Reston #ebolavirus be considered a livestock pathogen with potential to affect other mammals, including people, based on a new study of pigs. https:// bit.ly/3h7SEHM</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIH/status/1340132239045058560">
          <span class="id">1340132239045058560</span>
          NIH
          <span class="user">@NIH</span>
          <span class="time">2020-12-18 23:09:58</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><b><a href="https://twitter.com/NIH/status/1340132239045058560">NIH (@NIH)</a></b><br/><div><div lang="en" dir="auto"><span>Today </span><span><span><a dir="ltr" href="https://twitter.com/US_FDA" role="link" data-focusable="true">@US_FDA</a></span></span><span> granted Emergency Use Authorization to </span><span><span><a dir="ltr" href="https://twitter.com/moderna_tx" role="link" data-focusable="true">@moderna_tx</a></span></span><span> for </span><span><a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click" role="link" data-focusable="true">#COVID19</a></span><span> vaccine mRNA-1273. We are proud of the work by scientists at </span><span><a dir="ltr" href="https://twitter.com/hashtag/NIH?src=hashtag_click" role="link" data-focusable="true">#NIH</a></span><span>&#39;s </span><span><span><a dir="ltr" href="https://twitter.com/NIAIDNews" role="link" data-focusable="true">@NIAIDnews</a></span></span><span> who co-developed this urgently needed vaccine. </span><a dir="ltr" href="https://t.co/1LqivvTwXS?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">http://</span>bit.ly/38oqHb4</a></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIH/status/1340132239045058560/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="Image" data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EpkbAJcUUAEefZ7?format=jpg&amp;name=small&#34;);"></div><img alt="Image" draggable="true" src="https://pbs.twimg.com/media/EpkbAJcUUAEefZ7?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">NIH (@NIH) Today @US_FDA granted Emergency Use Authorization to @moderna_tx for #COVID19 vaccine mRNA-1273. We are proud of the work by scientists at #NIH &#39;s @NIAIDnews who co-developed this urgently needed vaccine. http:// bit.ly/38oqHb4</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1339671063844667392">
          <span class="id">1339671063844667392</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-17 16:37:26</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>COVID-19 NEWS: Today, two Phase 3 trials to test potential therapeutics for </span><span><a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click" role="link" data-focusable="true">#COVID19</a></span><span> began enrolling participants. The two trials, part of the ACTIV-3 master protocol, will test monoclonal </span><span><a dir="ltr" href="https://twitter.com/hashtag/antibody?src=hashtag_click" role="link" data-focusable="true">#antibody</a></span><span> therapeutics in hospitalized participants. </span><a dir="ltr" href="https://t.co/iWgSCbSnCC?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">http://</span>bit.ly/ACTIV3-GSK-VIR<span aria-hidden="true">-Brii</span><span aria-hidden="true">‚Ä¶</span></a></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIAIDNews/status/1339671063844667392/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="A scanning electron micrograph shows an apopototic cell (colored red) heavily infected with SARS-CoV-2 virus particles (colored yellow)" data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: -30%;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/Epd2qg-VEAELFLS?format=jpg&amp;name=small&#34;);"></div><img alt="A scanning electron micrograph shows an apopototic cell (colored red) heavily infected with SARS-CoV-2 virus particles (colored yellow)" draggable="true" src="https://pbs.twimg.com/media/Epd2qg-VEAELFLS?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">COVID-19 NEWS: Today, two Phase 3 trials to test potential therapeutics for #COVID19 began enrolling participants. The two trials, part of the ACTIV-3 master protocol, will test monoclonal #antibody therapeutics in hospitalized participants. http:// bit.ly/ACTIV3-GSK-VIR -Brii ‚Ä¶</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIH_CommonFund/status/1339608777452998656">
          <span class="id">1339608777452998656</span>
          NIH Common Fund
          <span class="user">@NIH_CommonFund</span>
          <span class="time">2020-12-17 12:29:55</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><b><a href="https://twitter.com/NIH_CommonFund/status/1339608777452998656">NIH Common Fund (@NIH_CommonFund)</a></b><br/><div><div lang="en" dir="auto"><span>Heard about our Cellular Senescence Network (</span><span><a dir="ltr" href="https://twitter.com/hashtag/SenNet?src=hashtag_click" role="link" data-focusable="true">#SenNet</a></span><span>) program? It aims to identify &amp; characterize senescent cells (which no longer replicate) across the body &amp; develop technology for studying </span><span><a dir="ltr" href="https://twitter.com/hashtag/senescence?src=hashtag_click" role="link" data-focusable="true">#senescence</a></span><span>. Read more on the </span><span><a dir="ltr" href="https://twitter.com/hashtag/NIHCommonFund?src=hashtag_click" role="link" data-focusable="true">#NIHCommonFund</a></span><span> site: </span><a dir="ltr" href="https://t.co/2fMYTdtQvi?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">http://</span>go.usa.gov/x7Vrn</a></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIH_CommonFund/status/1339608777452998656/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="Image announces a new program: The Cellular Senescence Network with URL commonfund.nih.gov/senescence" data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/Epc-YHfVQAgNX89?format=jpg&amp;name=small&#34;);"></div><img alt="Image announces a new program: The Cellular Senescence Network with URL commonfund.nih.gov/senescence" draggable="true" src="https://pbs.twimg.com/media/Epc-YHfVQAgNX89?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">NIH Common Fund (@NIH_CommonFund) Heard about our Cellular Senescence Network ( #SenNet ) program? It aims to identify &amp; characterize senescent cells (which no longer replicate) across the body &amp; develop technology for studying #senescence . Read more on the #NIHCommonFund site: http:// go.usa.gov/x7Vrn</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDFunding/status/1339325291349479424">
          <span class="id">1339325291349479424</span>
          NIAID Funding
          <span class="user">@NIAIDFunding</span>
          <span class="time">2020-12-16 17:43:27</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><b><a href="https://twitter.com/NIAIDFunding/status/1339325291349479424">NIAID Funding (@NIAIDFunding)</a></b><br/><div><div lang="en" dir="auto"><span>Funding News </span><a dir="ltr" href="https://t.co/bcjwsHlr2m?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">https://</span>niaid.nih.gov/grants-contrac<span aria-hidden="true">ts/funding-news</span><span aria-hidden="true">‚Ä¶</span></a><span>. Review application and award data from FY 2020, when to submit just-in-time information, genomic data sharing requirements, new initiatives, policy changes, and more!</span></div></div></div></div>
      <div class="text">NIAID Funding (@NIAIDFunding) Funding News https:// niaid.nih.gov/grants-contrac ts/funding-news ‚Ä¶ . Review application and award data from FY 2020, when to submit just-in-time information, genomic data sharing requirements, new initiatives, policy changes, and more!</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1339308308977618947">
          <span class="id">1339308308977618947</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-16 16:35:58</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span><a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click" role="link" data-focusable="true">#COVID19</a></span><span> NEWS: </span><span><span><a dir="ltr" href="https://twitter.com/NIAIDNews" role="link" data-focusable="true">@NIAIDNews</a></span></span><span> has launched a study to evaluate short- and long-term health outcomes of </span><span><a dir="ltr" href="https://twitter.com/hashtag/SARSCoV2?src=hashtag_click" role="link" data-focusable="true">#SARSCoV2</a></span><span> infection in </span><span><a dir="ltr" href="https://twitter.com/hashtag/children?src=hashtag_click" role="link" data-focusable="true">#children</a></span><span>, including MIS-C, and to characterize immunologic pathways associated with different disease presentations and outcomes. </span><a dir="ltr" href="https://t.co/vnz0ivYn9E?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">http://</span>bit.ly/SARSCoV2inKids</a></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIAIDNews/status/1339308308977618947/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.2482%;"></div><div><div aria-label="Image" data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EpYtnoMVoAADqZt?format=jpg&amp;name=small&#34;);"></div><img alt="Image" draggable="true" src="https://pbs.twimg.com/media/EpYtnoMVoAADqZt?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">#COVID19 NEWS: @NIAIDNews has launched a study to evaluate short- and long-term health outcomes of #SARSCoV2 infection in #children , including MIS-C, and to characterize immunologic pathways associated with different disease presentations and outcomes. http:// bit.ly/SARSCoV2inKids</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIH/status/1338548949620158465">
          <span class="id">1338548949620158465</span>
          NIH
          <span class="user">@NIH</span>
          <span class="time">2020-12-14 14:18:33</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><b><a href="https://twitter.com/NIH/status/1338548949620158465">NIH (@NIH)</a></b><br/><div><div lang="en" dir="auto"><span>Join us live on 12/15 at 2pm ET for a chat with </span><span><span><a dir="ltr" href="https://twitter.com/NIAIDNews" role="link" data-focusable="true">@NIAIDNews</a></span></span><span> Director Dr. Anthony Fauci &amp; </span><span><a dir="ltr" href="https://twitter.com/hashtag/NIH?src=hashtag_click" role="link" data-focusable="true">#NIH</a></span><span> Tribal Health Research Office Director Dr. David Wilson about the importance of </span><span><a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click" role="link" data-focusable="true">#COVID19</a></span><span> research, clinical trials &amp; vaccines within the </span><span><a dir="ltr" href="https://twitter.com/hashtag/AIAN?src=hashtag_click" role="link" data-focusable="true">#AIAN</a></span><span> community.</span></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIH/status/1338548949620158465/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 50%;"></div><div><div aria-label="Image" data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EpN7C3VUwAEUwk3?format=jpg&amp;name=small&#34;);"></div><img alt="Image" draggable="true" src="https://pbs.twimg.com/media/EpN7C3VUwAEUwk3?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">NIH (@NIH) Join us live on 12/15 at 2pm ET for a chat with @NIAIDNews Director Dr. Anthony Fauci &amp; #NIH Tribal Health Research Office Director Dr. David Wilson about the importance of #COVID19 research, clinical trials &amp; vaccines within the #AIAN community.</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1337460023807643648">
          <span class="id">1337460023807643648</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-11 14:11:33</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>COVID-19 NEWS: Today, a </span><span><a dir="ltr" href="https://twitter.com/hashtag/NIAID?src=hashtag_click" role="link" data-focusable="true">#NIAID</a></span><span> study of </span><span><a dir="ltr" href="https://twitter.com/hashtag/baricitinib?src=hashtag_click" role="link" data-focusable="true">#baricitinib</a></span><span> and </span><span><a dir="ltr" href="https://twitter.com/hashtag/remdesivir?src=hashtag_click" role="link" data-focusable="true">#remdesivir</a></span><span> for people hospitalized with </span><span><a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click" role="link" data-focusable="true">#COVID19</a></span><span> published in </span><span><span><a dir="ltr" href="https://twitter.com/NEJM" role="link" data-focusable="true">@NEJM</a></span></span><span>. Participants who received the combination did better than those who received remdesivir alone. </span><a dir="ltr" href="https://t.co/CxnUNNROy5?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">http://</span>bit.ly/ACTT2NEJM</a></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIAIDNews/status/1337460023807643648/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="A particle of the SARS-CoV-2 virus, isolated from a patient, colored yellow" data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: -15%;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/Eo-cq4BXUAAcHjr?format=jpg&amp;name=small&#34;);"></div><img alt="A particle of the SARS-CoV-2 virus, isolated from a patient, colored yellow" draggable="true" src="https://pbs.twimg.com/media/Eo-cq4BXUAAcHjr?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">COVID-19 NEWS: Today, a #NIAID study of #baricitinib and #remdesivir for people hospitalized with #COVID19 published in @NEJM . Participants who received the combination did better than those who received remdesivir alone. http:// bit.ly/ACTT2NEJM</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1334603847973679104">
          <span class="id">1334603847973679104</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-03 17:02:07</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>Natural infection with SARS-CoV-2 does not always lead to durable immunity to the virus. These results suggest that the mRNA-1273 vaccine could provide long-term protection.</span></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIAIDNews/status/1334603847973679104/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="Several round particles of SARS-CoV-2, the virus which causes COVID-19, colored blue." data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: -15%;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EoV2tqnXUAwFuOM?format=jpg&amp;name=small&#34;);"></div><img alt="Several round particles of SARS-CoV-2, the virus which causes COVID-19, colored blue." draggable="true" src="https://pbs.twimg.com/media/EoV2tqnXUAwFuOM?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">Natural infection with SARS-CoV-2 does not always lead to durable immunity to the virus. These results suggest that the mRNA-1273 vaccine could provide long-term protection.</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1334603845993979906">
          <span class="id">1334603845993979906</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-03 17:02:07</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>Participants had sustained, elevated levels of </span><span><a dir="ltr" href="https://twitter.com/hashtag/antibodies?src=hashtag_click" role="link" data-focusable="true">#antibodies</a></span><span> against the virus which causes </span><span><a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click" role="link" data-focusable="true">#COVID19</a></span><span>, despite some decline in antibody titers over time. This suggests that the vaccine could provide durable humoral immunity against the virus.</span></div></div></div></div>
      <div class="text">Participants had sustained, elevated levels of #antibodies against the virus which causes #COVID19 , despite some decline in antibody titers over time. This suggests that the vaccine could provide durable humoral immunity against the virus.</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1334603843649331203">
          <span class="id">1334603843649331203</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-03 17:02:06</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>The study tracked participants for 119 days after receiving their first dose of the vaccine; three months after the second dose. Blood tests were used to track the levels of antibodies against SARS-CoV-2, the virus which causes </span><span><a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click" role="link" data-focusable="true">#COVID19</a></span><span>, in their blood.</span></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIAIDNews/status/1334603843649331203/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="An image showing a particle of SARS-CoV-2, the virus which causes COVID-19." data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: -15%;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EoV2bQFXYAM2HJy?format=jpg&amp;name=small&#34;);"></div><img alt="An image showing a particle of SARS-CoV-2, the virus which causes COVID-19." draggable="true" src="https://pbs.twimg.com/media/EoV2bQFXYAM2HJy?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">The study tracked participants for 119 days after receiving their first dose of the vaccine; three months after the second dose. Blood tests were used to track the levels of antibodies against SARS-CoV-2, the virus which causes #COVID19 , in their blood.</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1334603841883566082">
          <span class="id">1334603841883566082</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-03 17:02:06</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>COVID-19 NEWS: In a letter published in </span><span><span><a dir="ltr" href="https://twitter.com/NEJM" role="link" data-focusable="true">@NEJM</a></span></span><span> today, researchers from </span><span><a dir="ltr" href="https://twitter.com/hashtag/NIAID?src=hashtag_click" role="link" data-focusable="true">#NIAID</a></span><span> and partners describe the long-term immunogenicity results from a phase 1 trial of the mRNA-1273 </span><span><a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click" role="link" data-focusable="true">#COVID19</a></span><span> </span><span><a dir="ltr" href="https://twitter.com/hashtag/vaccine?src=hashtag_click" role="link" data-focusable="true">#vaccine</a></span><span>:</span></div></div><hr/><br/><div><div><div><div><div data-testid="card.wrapper"><div aria-hidden="true" data-testid="card.layoutSmall.media" style="width: calc(124.438px);"><a href="https://t.co/CKWoz07Npd?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><div><div style="padding-bottom: 100%;"></div><div><div aria-label="" style="margin-bottom: 0px; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/card_img/1342161591744262144/1tZ72Ny7?format=jpg&amp;name=240x240&#34;);"></div><img alt="" draggable="true" src="https://pbs.twimg.com/card_img/1342161591744262144/1tZ72Ny7?format=jpg&amp;name=240x240"/></div></div></div></a></div><div><a href="https://t.co/CKWoz07Npd?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><div data-testid="card.layoutSmall.detail"><div><div dir="auto"><span><span><b>Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination | NEJM</b></span></span></div></div><div><div dir="auto" style="-webkit-line-clamp: 2;"><span><span>Correspondence from The New England Journal of Medicine ‚Äî Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination</span></span></div></div><div><div dir="auto"><span><svg viewBox="0 0 24 24"><g><path d="M11.96 14.945c-.067 0-.136-.01-.203-.027-1.13-.318-2.097-.986-2.795-1.932-.832-1.125-1.176-2.508-.968-3.893s.942-2.605 2.068-3.438l3.53-2.608c2.322-1.716 5.61-1.224 7.33 1.1.83 1.127 1.175 2.51.967 3.895s-.943 2.605-2.07 3.438l-1.48 1.094c-.333.246-.804.175-1.05-.158-.246-.334-.176-.804.158-1.05l1.48-1.095c.803-.592 1.327-1.463 1.476-2.45.148-.988-.098-1.975-.69-2.778-1.225-1.656-3.572-2.01-5.23-.784l-3.53 2.608c-.802.593-1.326 1.464-1.475 2.45-.15.99.097 1.975.69 2.778.498.675 1.187 1.15 1.992 1.377.4.114.633.528.52.928-.092.33-.394.547-.722.547z"></path><path d="M7.27 22.054c-1.61 0-3.197-.735-4.225-2.125-.832-1.127-1.176-2.51-.968-3.894s.943-2.605 2.07-3.438l1.478-1.094c.334-.245.805-.175 1.05.158s.177.804-.157 1.05l-1.48 1.095c-.803.593-1.326 1.464-1.475 2.45-.148.99.097 1.975.69 2.778 1.225 1.657 3.57 2.01 5.23.785l3.528-2.608c1.658-1.225 2.01-3.57.785-5.23-.498-.674-1.187-1.15-1.992-1.376-.4-.113-.633-.527-.52-.927.112-.4.528-.63.926-.522 1.13.318 2.096.986 2.794 1.932 1.717 2.324 1.224 5.612-1.1 7.33l-3.53 2.608c-.933.693-2.023 1.026-3.105 1.026z"></path></g></svg></span><span><span><i>nejm.org</i></span></span></div></div></div></a></div></div></div></div></div></div></div></div>
      <div class="text">COVID-19 NEWS: In a letter published in @NEJM today, researchers from #NIAID and partners describe the long-term immunogenicity results from a phase 1 trial of the mRNA-1273 #COVID19 #vaccine : Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination | NEJM Correspondence from The New England Journal of Medicine ‚Äî Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination nejm.org</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDFunding/status/1334193608078086144">
          <span class="id">1334193608078086144</span>
          NIAID Funding
          <span class="user">@NIAIDFunding</span>
          <span class="time">2020-12-02 13:51:58</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><b><a href="https://twitter.com/NIAIDFunding/status/1334193608078086144">NIAID Funding (@NIAIDFunding)</a></b><br/><div><div lang="en" dir="auto"><span>Funding News </span><a dir="ltr" href="https://t.co/bcjwsHD2qW?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">https://</span>niaid.nih.gov/grants-contrac<span aria-hidden="true">ts/funding-news</span><span aria-hidden="true">‚Ä¶</span></a><span>. Find advice on writing your application‚Äôs budget section, correctly labeling research roles, preparing for the new data sharing policy, and more!</span></div></div></div></div>
      <div class="text">NIAID Funding (@NIAIDFunding) Funding News https:// niaid.nih.gov/grants-contrac ts/funding-news ‚Ä¶ . Find advice on writing your application‚Äôs budget section, correctly labeling research roles, preparing for the new data sharing policy, and more!</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIH/status/1334168788447596545">
          <span class="id">1334168788447596545</span>
          NIH
          <span class="user">@NIH</span>
          <span class="time">2020-12-02 12:13:21</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><b><a href="https://twitter.com/NIH/status/1334168788447596545">NIH (@NIH)</a></b><br/><div><div lang="en" dir="auto"><span>Find </span><span><a dir="ltr" href="https://twitter.com/hashtag/NIH?src=hashtag_click" role="link" data-focusable="true">#NIH</a></span><span> </span><span><a dir="ltr" href="https://twitter.com/hashtag/COVID19?src=hashtag_click" role="link" data-focusable="true">#COVID19</a></span><span> Phase 2 &amp; 3 prevention and treatment </span><span><a dir="ltr" href="https://twitter.com/hashtag/clinicaltrials?src=hashtag_click" role="link" data-focusable="true">#clinicaltrials</a></span><span> as well as info on plasma &amp; blood donation on the </span><span><span><a dir="ltr" href="https://twitter.com/HHSGov" role="link" data-focusable="true">@HHSgov</a></span></span><span> web portal. Join the effort to find safe &amp; effective vaccines and treatments! </span><a dir="ltr" href="https://t.co/d5IfjldG9h?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">https://</span>combatcovid.hhs.gov</a></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIH/status/1334168788447596545/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="Image" data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EoPrXWTVgAAu3FA?format=jpg&amp;name=small&#34;);"></div><img alt="Image" draggable="true" src="https://pbs.twimg.com/media/EoPrXWTVgAAu3FA?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">NIH (@NIH) Find #NIH #COVID19 Phase 2 &amp; 3 prevention and treatment #clinicaltrials as well as info on plasma &amp; blood donation on the @HHSgov web portal. Join the effort to find safe &amp; effective vaccines and treatments! https:// combatcovid.hhs.gov</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIDAnews/status/1333759426071769089">
          <span class="id">1333759426071769089</span>
          nidanews
          <span class="user">@NIDAnews</span>
          <span class="time">2020-12-01 09:06:41</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><b><a href="https://twitter.com/NIDAnews/status/1333759426071769089">nidanews (@NIDAnews)</a></b><br/><div><div lang="en" dir="auto"><span>This </span><span><a dir="ltr" href="https://twitter.com/hashtag/WorldAIDSDay?src=hashtag_click" role="link" data-focusable="true">#WorldAIDSDay</a></span><span>, NIDA Director Dr. Nora Volkow discusses drug use, sex and HIV ‚Äì and how coordination is critical in responding to the linked epidemics of </span><span><a dir="ltr" href="https://twitter.com/hashtag/HIV?src=hashtag_click" role="link" data-focusable="true">#HIV</a></span><span> and addiction.<br/>
</span><a dir="ltr" href="https://t.co/w5hUrszV49?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">https://</span>loom.ly/KblaYr8</a><span><br/>
</span><span><a dir="ltr" href="https://twitter.com/hashtag/WAD2020?src=hashtag_click" role="link" data-focusable="true">#WAD2020</a></span></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIDAnews/status/1333759426071769089/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="Image" data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: -9%;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EoJ3IFjXUAA75oF?format=jpg&amp;name=small&#34;);"></div><img alt="Image" draggable="true" src="https://pbs.twimg.com/media/EoJ3IFjXUAA75oF?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">nidanews (@NIDAnews) This #WorldAIDSDay , NIDA Director Dr. Nora Volkow discusses drug use, sex and HIV ‚Äì and how coordination is critical in responding to the linked epidemics of #HIV and addiction. https:// loom.ly/KblaYr8 #WAD2020</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1333778025855528960">
          <span class="id">1333778025855528960</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-12-01 10:20:36</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>On </span><span><a dir="ltr" href="https://twitter.com/hashtag/WorldAIDSDay?src=hashtag_click" role="link" data-focusable="true">#WorldAIDSDay</a></span><span>, </span><span><span><a dir="ltr" href="https://twitter.com/NIH" role="link" data-focusable="true">@NIH</a></span></span><span> reflects on both the remarkable progress that has been made against </span><span><a dir="ltr" href="https://twitter.com/hashtag/HIV?src=hashtag_click" role="link" data-focusable="true">#HIV</a></span><span> &amp; the considerable challenges that remain. Read a statement from </span><span><span><a dir="ltr" href="https://twitter.com/NIAIDNews" role="link" data-focusable="true">@NIAIDNews</a></span></span><span> Director Dr. Fauci &amp; </span><span><span><a dir="ltr" href="https://twitter.com/NIH_OAR" role="link" data-focusable="true">@NIH_OAR</a></span></span><span> Director Dr. Goodenow: </span><a dir="ltr" href="https://t.co/z2zvEeUbLI?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">https://</span>bit.ly/NIHWAD2020</a></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIAIDNews/status/1333778025855528960/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="A man&#39;s hand holding a red HIV/AIDS awareness ribbon" data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EoKH0ewXcAAx6DV?format=jpg&amp;name=small&#34;);"></div><img alt="A man&#39;s hand holding a red HIV/AIDS awareness ribbon" draggable="true" src="https://pbs.twimg.com/media/EoKH0ewXcAAx6DV?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">On #WorldAIDSDay , @NIH reflects on both the remarkable progress that has been made against #HIV &amp; the considerable challenges that remain. Read a statement from @NIAIDNews Director Dr. Fauci &amp; @NIH_OAR Director Dr. Goodenow: https:// bit.ly/NIHWAD2020</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1333507438063083523">
          <span class="id">1333507438063083523</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-11-30 16:25:23</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span><a dir="ltr" href="https://twitter.com/hashtag/HIV?src=hashtag_click" role="link" data-focusable="true">#HIV</a></span><span> NEWS: </span><span><span><a dir="ltr" href="https://twitter.com/NIAIDNews" role="link" data-focusable="true">@NIAIDNews</a></span></span><span> today announced the investigators &amp; institutions that will lead 4 </span><span><span><a dir="ltr" href="https://twitter.com/NIH" role="link" data-focusable="true">@NIH</a></span></span><span> HIV </span><span><a dir="ltr" href="https://twitter.com/hashtag/ClinicalTrials?src=hashtag_click" role="link" data-focusable="true">#ClinicalTrials</a></span><span> networks over the next 7 years. NIAID also awarded grants to 35 institutions selected as HIV clinical trials units. </span><a dir="ltr" href="https://t.co/5ztbXPSrgR?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">https://</span>bit.ly/HIVnetworks</a></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIAIDNews/status/1333507438063083523/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="Red ribbon for HIV/AIDS awareness" data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EoGR5f9XEAgTkwN?format=jpg&amp;name=small&#34;);"></div><img alt="Red ribbon for HIV/AIDS awareness" draggable="true" src="https://pbs.twimg.com/media/EoGR5f9XEAgTkwN?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">#HIV NEWS: @NIAIDNews today announced the investigators &amp; institutions that will lead 4 @NIH HIV #ClinicalTrials networks over the next 7 years. NIAID also awarded grants to 35 institutions selected as HIV clinical trials units. https:// bit.ly/HIVnetworks</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1333493097745956864">
          <span class="id">1333493097745956864</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-11-30 15:28:24</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span><a dir="ltr" href="https://twitter.com/hashtag/PeanutAllergy?src=hashtag_click" role="link" data-focusable="true">#PeanutAllergy</a></span><span> NEWS: </span><span><span><a dir="ltr" href="https://twitter.com/NIAIDNews" role="link" data-focusable="true">@NIAIDNews</a></span></span><span> is supporting a study to improve </span><span><a dir="ltr" href="https://twitter.com/hashtag/pediatric?src=hashtag_click" role="link" data-focusable="true">#pediatric</a></span><span> clinicians‚Äô adherence to the Addendum Guidelines for the Prevention of </span><span><a dir="ltr" href="https://twitter.com/hashtag/Peanut?src=hashtag_click" role="link" data-focusable="true">#Peanut</a></span><span> </span><span><a dir="ltr" href="https://twitter.com/hashtag/Allergy?src=hashtag_click" role="link" data-focusable="true">#Allergy</a></span><span> using an education module and a new tool in the Electronic Health Record. </span><a dir="ltr" href="https://t.co/iRXqvnjCOG?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">https://</span>clinicaltrials.gov/ct2/show/NCT04<span aria-hidden="true">604431</span><span aria-hidden="true">‚Ä¶</span></a></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIAIDNews/status/1333493097745956864/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="Image" data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EoGEzxLVQAE7_eh?format=jpg&amp;name=small&#34;);"></div><img alt="Image" draggable="true" src="https://pbs.twimg.com/media/EoGEzxLVQAE7_eh?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">#PeanutAllergy NEWS: @NIAIDNews is supporting a study to improve #pediatric clinicians‚Äô adherence to the Addendum Guidelines for the Prevention of #Peanut #Allergy using an education module and a new tool in the Electronic Health Record. https:// clinicaltrials.gov/ct2/show/NCT04 604431 ‚Ä¶</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIAIDNews/status/1333476599367307269">
          <span class="id">1333476599367307269</span>
          NIAID News
          <span class="user">@NIAIDNews</span>
          <span class="time">2020-11-30 14:22:50</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><div><div lang="en" dir="auto"><span>NEWS: An experimental vaccine developed in Europe to prevent infection by </span><span><a dir="ltr" href="https://twitter.com/hashtag/Crimean?src=hashtag_click" role="link" data-focusable="true">#Crimean</a></span><span> Congo hemorrhagic fever virus has protected cynomolgus macaques in a new NIAID collaborative study. </span><a dir="ltr" href="https://t.co/SrGKY3mwac?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">https://</span>bit.ly/3o9F1dv</a></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIAIDNews/status/1333476599367307269/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="Map showing where CCHFV is endemic" data-testid="tweetPhoto" style="margin-bottom: -10%; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EoF1xQCVcAA-U_N?format=jpg&amp;name=small&#34;);"></div><img alt="Map showing where CCHFV is endemic" draggable="true" src="https://pbs.twimg.com/media/EoF1xQCVcAA-U_N?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">NEWS: An experimental vaccine developed in Europe to prevent infection by #Crimean Congo hemorrhagic fever virus has protected cynomolgus macaques in a new NIAID collaborative study. https:// bit.ly/3o9F1dv</div>
    </div>
    <hr class="sep"><div class="tweet">
      <div class="head">
        <a href="https://twitter.com/NIH_OAR/status/1331614501028978691">
          <span class="id">1331614501028978691</span>
          NIH OAR
          <span class="user">@NIH_OAR</span>
          <span class="time">2020-11-25 11:03:31</span>
        </a>
      </div>
      <hr>
      <div class="content"><div><b><a href="https://twitter.com/NIH_OAR/status/1331614501028978691">NIH OAR (@NIH_OAR)</a></b><br/><div><div lang="en" dir="auto"><span>Join </span><span><span><a dir="ltr" href="https://twitter.com/NIH_OAR" role="link" data-focusable="true">@NIH_OAR</a></span></span><span> December 1st at 11:00am for the virtual </span><span><a dir="ltr" href="https://twitter.com/hashtag/NIH?src=hashtag_click" role="link" data-focusable="true">#NIH</a></span><span> </span><span><a dir="ltr" href="https://twitter.com/hashtag/WorldAIDSDay?src=hashtag_click" role="link" data-focusable="true">#WorldAIDSDay</a></span><span> observance </span><a dir="ltr" href="https://t.co/9HB1rsxC0Q?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">http://</span>ow.ly/hTDr50CsIks</a><span>. Agenda &amp; speakers bios available </span><a dir="ltr" href="https://t.co/pjIPAYaqF3?amp=1" target="_blank" role="link" data-focusable="true" rel=" noopener noreferrer"><span aria-hidden="true">http://</span>ow.ly/3PJN50CsIkr</a><span>. </span><span><a dir="ltr" href="https://twitter.com/hashtag/WAD2020?src=hashtag_click" role="link" data-focusable="true">#WAD2020</a></span></div></div><hr/><br/><div><div><div><div><div><a href="https://twitter.com/NIH_OAR/status/1331614501028978691/photo/1" role="link" data-focusable="true"><div style=""><div style="padding-bottom: 56.25%;"></div><div><div aria-label="Image" data-testid="tweetPhoto" style="margin-bottom: 0px; margin-top: 0px;"><div style="background-image: url(&#34;https://pbs.twimg.com/media/EnrYVQ2W8AAp29S?format=jpg&amp;name=small&#34;);"></div><img alt="Image" draggable="true" src="https://pbs.twimg.com/media/EnrYVQ2W8AAp29S?format=jpg&amp;name=small"/></div></div></div></a></div></div></div></div></div></div></div>
      <div class="text">NIH OAR (@NIH_OAR) Join @NIH_OAR December 1st at 11:00am for the virtual #NIH #WorldAIDSDay observance http:// ow.ly/hTDr50CsIks . Agenda &amp; speakers bios available http:// ow.ly/3PJN50CsIkr . #WAD2020</div>
    </div>
    <hr class="sep">
  </body>
</html>